bioAffinity Technologies, Inc. Warrant
BIAFW
BIAFW
5 hedge funds and large institutions have $105K invested in bioAffinity Technologies, Inc. Warrant in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
$17.1K |
| 2 |
OC
Oarsman Capital
Milwaukee,
Wisconsin
|
$733 |
| 3 |
CS
Clear Street
New York
|
$18.5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
$199 |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $68.7K | – | – | – |
|
|
CS
2
Clear Street
New York
| $18.5K | +$67 | +200 | +0.4% |
|
|
3
Citadel Advisors
Miami,
Florida
| $17.1K | +$3.76K | +11,065 | +28% |
|
|
OC
4
Oarsman Capital
Milwaukee,
Wisconsin
| $733 | +$733 | +2,448 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $199 | +$59 | +198 | +42% |
|